Clarus Wealth Advisors Has $1.53 Million Holdings in iShares Biotechnology ETF (NASDAQ:IBB)

Clarus Wealth Advisors raised its position in shares of iShares Biotechnology ETF (NASDAQ:IBB) by 1.4% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 11,383 shares of the financial services provider’s stock after buying an additional 161 shares during the period. Clarus Wealth Advisors’ holdings in iShares Biotechnology ETF were worth $1,526,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds also recently modified their holdings of the company. Darwin Wealth Management LLC bought a new stake in iShares Biotechnology ETF during the 3rd quarter worth approximately $29,000. Highline Wealth Partners LLC acquired a new position in iShares Biotechnology ETF in the third quarter worth $30,000. Ashton Thomas Securities LLC bought a new stake in shares of iShares Biotechnology ETF during the third quarter worth $36,000. Modus Advisors LLC acquired a new stake in shares of iShares Biotechnology ETF in the fourth quarter valued at $41,000. Finally, Voisard Asset Management Group Inc. bought a new position in shares of iShares Biotechnology ETF in the third quarter valued at about $59,000. Institutional investors and hedge funds own 62.45% of the company’s stock.

iShares Biotechnology ETF Trading Down 1.8 %

Shares of NASDAQ IBB opened at $131.57 on Wednesday. iShares Biotechnology ETF has a 12-month low of $123.60 and a 12-month high of $150.57. The firm’s 50-day simple moving average is $137.51 and its 200 day simple moving average is $141.93.

iShares Biotechnology ETF Cuts Dividend

The business also recently announced a dividend, which was paid on Friday, December 20th. Stockholders of record on Tuesday, December 17th were given a dividend of $0.0624 per share. The ex-dividend date of this dividend was Tuesday, December 17th.

About iShares Biotechnology ETF

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.